Evidence map›Paper›PMID 31006814›Full record

ArticleNucleic acids research2019

Interplay of primary sequence, position and secondary RNA structure determines alternative splicing of LMNA in a pre-mature aging syndrome.

Asaf Shilo, Frances Anne Tosto, Jason W Rausch, Stuart F J Le Grice, Tom Misteli

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Precise progerin targeting using RfxCas13d: A therapeutic avenue for Hutchinson-Gilford progeria syndrome.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Asaf ShiloCell Biology of Genomes, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Frances Anne TostoCell Biology of Genomes, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Jason W RauschBasic Research Laboratory, National Cancer Institute, NIH, Frederick, MD 21702, USA.
Stuart F J Le GriceBasic Research Laboratory, National Cancer Institute, NIH, Frederick, MD 21702, USA.
Tom MisteliCell Biology of Genomes, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
National Cancer Institute · US

Funding

Structural studies with regulatory RNAsZIABC011824 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LE GRICE, STUART F. J. · 2018 to 2021
$1.6M
6 · The paper itself

Abstract

Aberrant splicing in exon 11 of the LMNA gene causes the premature aging disorder Hutchinson-Gilford Progeria Syndrome. A de novo C1824T mutation activates an internal alternative 5' splice site, resulting in formation of the disease-causing progerin protein. The underlying mechanism for this 5' splice site selection is unknown. Here, we have applied a combination of targeted mutational analysis in a cell-based system and structural mapping by SHAPE-MaP to comprehensively probe the contributions of primary sequence, secondary RNA structure and linear splice site position in determining in vivo mechanisms of splice site choice in LMNA. While splice site choice is in part defined by sequence complementarity to U1 snRNA, we identify RNA secondary structural elements near the alternative 5' splice sites and show that splice site choice is significantly influenced by the structural context of the available splice sites. Furthermore, relative positioning of the competing sites within the primary sequence of the pre-mRNA is a predictor of 5' splice site usage, with the distal position favored over the proximal, regardless of sequence composition. Together, these results demonstrate that 5' splice site selection in LMNA is determined by an intricate interplay among RNA sequence, secondary structure and splice site position.

Indexed as

Alternative SplicingDNA Mutational AnalysisExonsFibroblastsHEK293 CellsHumansLamin Type AMutationNuclear ProteinsNucleic Acid ConformationPoint MutationProgeriaProtein Structure, SecondaryRNARNA, Small NuclearRNA Splice SitesLamin Type ALMNA protein, humanNuclear ProteinsRNARNA, Small NuclearRNA Splice SitesU1 small nuclear RNA

Identifiers

PMID31006814
PMCPMC6582319
OpenAlexW2940960550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.